These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4053270)

  • 1. High dose melphalan in children with advanced malignant disease. A pharmacokinetic study.
    Ninane J; Baurain R; de Selys A; Trouet A; Cornu G
    Cancer Chemother Pharmacol; 1985; 15(3):263-7. PubMed ID: 4053270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of melphalan in children following high-dose intravenous injection.
    Taha IA; Ahmad RA; Rogers DW; Pritchard J; Rogers HJ
    Cancer Chemother Pharmacol; 1983; 10(3):212-6. PubMed ID: 6861266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous melphalan: a review.
    Samuels BL; Bitran JD
    J Clin Oncol; 1995 Jul; 13(7):1786-99. PubMed ID: 7602368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases.
    Ardiet C; Tranchand B; Biron P; Rebattu P; Philip T
    Cancer Chemother Pharmacol; 1986; 16(3):300-5. PubMed ID: 3516430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of high-dose melphalan in children and adults.
    Gouyette A; Hartmann O; Pico JL
    Cancer Chemother Pharmacol; 1986; 16(2):184-9. PubMed ID: 3948304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
    Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S
    Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies with melphalan and pediatric neoplastic and normal bone marrow cells.
    Worthington-White DA; Graham-Pole JR; Stout SA; Riley CM
    Int J Cancer; 1986 Jun; 37(6):819-23. PubMed ID: 3458679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration.
    Dourthe ME; Ternès N; Gajda D; Paci A; Dufour C; Benhamou E; Valteau-Couanet D
    Bone Marrow Transplant; 2016 Sep; 51(9):1265-7. PubMed ID: 27111042
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.
    Hartmann O; Kalifa C; Benhamou E; Patte C; Flamant F; Jullien C; Beaujean F; Lemerle J
    Cancer Chemother Pharmacol; 1986; 16(2):165-9. PubMed ID: 3512113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
    Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG
    J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
    Pritchard J; McElwain TJ; Graham-Pole J
    Br J Cancer; 1982 Jan; 45(1):86-94. PubMed ID: 7037033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.
    Drabko K; Raciborska A; Bilska K; Styczynski J; Ussowicz M; Choma M; Wojcik B; Zaucha-Prazmo A; Gorczynska E; Skoczen S; Wozniak W; Chybicka A; Wysocki M; Gozdzik J; Kowalczyk J
    Bone Marrow Transplant; 2012 Dec; 47(12):1530-4. PubMed ID: 22609883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation.
    Pinguet F; Martel P; Fabbro M; Petit I; Canal P; Culine S; Astre C; Bressolle F
    Anticancer Res; 1997; 17(1B):605-11. PubMed ID: 9066587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
    Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
    Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma.
    Corbett R; Pinkerton R; Pritchard J; Meller S; Lewis I; Kingston J; McElwain T
    Eur J Cancer; 1992; 28A(8-9):1324-8. PubMed ID: 1515243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma.
    Sutow WW; Vietti TJ; Fernbach DJ; Lane DM; Donaldson MH; Lonsdale D
    Cancer Chemother Rep; 1971 Feb; 55(1):67-78. PubMed ID: 5287340
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of high dose melphalan.
    Hersh MR; Ludden TM; Kuhn JG; Knight WA
    Invest New Drugs; 1983; 1(4):331-4. PubMed ID: 6678879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion.
    Choi KE; Ratain MJ; Williams SF; Golick JA; Beschorner JC; Fullem LJ; Bitran JD
    Cancer Res; 1989 Mar; 49(5):1318-21. PubMed ID: 2645050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.